Cargando…
A Clinical Study of Cutaneous Adverse Reactions to Nonionic Contrast Media in Korea
BACKGROUND: The use of intravenous contrast media (CM) has increased for the diagnosis of several diseases. The newly developed low osmolar nonionic contrast agents cause significantly decreased adverse reactions than the higher osmolar ones. However, adverse reactions may still occur, ranging in se...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Dermatological Association; The Korean Society for Investigative Dermatology
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3283846/ https://www.ncbi.nlm.nih.gov/pubmed/22363151 http://dx.doi.org/10.5021/ad.2012.24.1.22 |
_version_ | 1782224266786242560 |
---|---|
author | Jung, Kyung Eun Chung, Jimin Park, Byung Cheol Jee, Keum Nahn Jee, Young Koo Kim, Myung Hwa |
author_facet | Jung, Kyung Eun Chung, Jimin Park, Byung Cheol Jee, Keum Nahn Jee, Young Koo Kim, Myung Hwa |
author_sort | Jung, Kyung Eun |
collection | PubMed |
description | BACKGROUND: The use of intravenous contrast media (CM) has increased for the diagnosis of several diseases. The newly developed low osmolar nonionic contrast agents cause significantly decreased adverse reactions than the higher osmolar ones. However, adverse reactions may still occur, ranging in severity from minor side effects to severe complications. However, there have been few reports about cutaneous adverse reactions (CARs) to nonionic monomer CM. OBJECTIVE: The purpose of this study was to evaluate clinical features of CAR to intravenous nonionic monomer CM. METHODS: A total 47,338 examinees underwent intravenous iodinated contrast-enhanced computed tomography scan using nonionic monomer CM. Among the adverse reactions to the CM, we divided them into cutaneous or noncutaneous and immediate (<1 hr) or late (≥1 hr) adverse reactions. RESULTS: Adverse reactions were noted in 62 cases out of the total 47,338 cases; 50 cases (80.7%) were categorized CARs. Among them, there were 24 male and 26 female patients. There was no significant difference between the sexes, and CARs occurred in all age groups. The highest occurrence was in the age range of 50~59 years. CARs included urticaria (78%), angioedema (10%), maculopapular rash (8%), erythema (2%), and pruritus without rash (2%). Immediate reactions were 92% (46 cases), while late reactions were 8% (4 cases). CONCLUSION: CARs to nonionic monomer CM accounted for most of the adverse reactions (80.7%) and urticaria was the most common. |
format | Online Article Text |
id | pubmed-3283846 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2012 |
publisher | Korean Dermatological Association; The Korean Society for Investigative Dermatology |
record_format | MEDLINE/PubMed |
spelling | pubmed-32838462012-02-23 A Clinical Study of Cutaneous Adverse Reactions to Nonionic Contrast Media in Korea Jung, Kyung Eun Chung, Jimin Park, Byung Cheol Jee, Keum Nahn Jee, Young Koo Kim, Myung Hwa Ann Dermatol Original Article BACKGROUND: The use of intravenous contrast media (CM) has increased for the diagnosis of several diseases. The newly developed low osmolar nonionic contrast agents cause significantly decreased adverse reactions than the higher osmolar ones. However, adverse reactions may still occur, ranging in severity from minor side effects to severe complications. However, there have been few reports about cutaneous adverse reactions (CARs) to nonionic monomer CM. OBJECTIVE: The purpose of this study was to evaluate clinical features of CAR to intravenous nonionic monomer CM. METHODS: A total 47,338 examinees underwent intravenous iodinated contrast-enhanced computed tomography scan using nonionic monomer CM. Among the adverse reactions to the CM, we divided them into cutaneous or noncutaneous and immediate (<1 hr) or late (≥1 hr) adverse reactions. RESULTS: Adverse reactions were noted in 62 cases out of the total 47,338 cases; 50 cases (80.7%) were categorized CARs. Among them, there were 24 male and 26 female patients. There was no significant difference between the sexes, and CARs occurred in all age groups. The highest occurrence was in the age range of 50~59 years. CARs included urticaria (78%), angioedema (10%), maculopapular rash (8%), erythema (2%), and pruritus without rash (2%). Immediate reactions were 92% (46 cases), while late reactions were 8% (4 cases). CONCLUSION: CARs to nonionic monomer CM accounted for most of the adverse reactions (80.7%) and urticaria was the most common. Korean Dermatological Association; The Korean Society for Investigative Dermatology 2012-02 2012-02-02 /pmc/articles/PMC3283846/ /pubmed/22363151 http://dx.doi.org/10.5021/ad.2012.24.1.22 Text en Copyright © 2012 Korean Dermatological Association; The Korean Society for Investigative Dermatology http://creativecommons.org/licenses/by-nc/3.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Article Jung, Kyung Eun Chung, Jimin Park, Byung Cheol Jee, Keum Nahn Jee, Young Koo Kim, Myung Hwa A Clinical Study of Cutaneous Adverse Reactions to Nonionic Contrast Media in Korea |
title | A Clinical Study of Cutaneous Adverse Reactions to Nonionic Contrast Media in Korea |
title_full | A Clinical Study of Cutaneous Adverse Reactions to Nonionic Contrast Media in Korea |
title_fullStr | A Clinical Study of Cutaneous Adverse Reactions to Nonionic Contrast Media in Korea |
title_full_unstemmed | A Clinical Study of Cutaneous Adverse Reactions to Nonionic Contrast Media in Korea |
title_short | A Clinical Study of Cutaneous Adverse Reactions to Nonionic Contrast Media in Korea |
title_sort | clinical study of cutaneous adverse reactions to nonionic contrast media in korea |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3283846/ https://www.ncbi.nlm.nih.gov/pubmed/22363151 http://dx.doi.org/10.5021/ad.2012.24.1.22 |
work_keys_str_mv | AT jungkyungeun aclinicalstudyofcutaneousadversereactionstononioniccontrastmediainkorea AT chungjimin aclinicalstudyofcutaneousadversereactionstononioniccontrastmediainkorea AT parkbyungcheol aclinicalstudyofcutaneousadversereactionstononioniccontrastmediainkorea AT jeekeumnahn aclinicalstudyofcutaneousadversereactionstononioniccontrastmediainkorea AT jeeyoungkoo aclinicalstudyofcutaneousadversereactionstononioniccontrastmediainkorea AT kimmyunghwa aclinicalstudyofcutaneousadversereactionstononioniccontrastmediainkorea AT jungkyungeun clinicalstudyofcutaneousadversereactionstononioniccontrastmediainkorea AT chungjimin clinicalstudyofcutaneousadversereactionstononioniccontrastmediainkorea AT parkbyungcheol clinicalstudyofcutaneousadversereactionstononioniccontrastmediainkorea AT jeekeumnahn clinicalstudyofcutaneousadversereactionstononioniccontrastmediainkorea AT jeeyoungkoo clinicalstudyofcutaneousadversereactionstononioniccontrastmediainkorea AT kimmyunghwa clinicalstudyofcutaneousadversereactionstononioniccontrastmediainkorea |